Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-3628
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

O2-8-5Prognostic Value of Subtype Changes After Neoadjuvant Chemotherapy in Primary Breast Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

Neoadjuvant Chemotherapy in Breast Cancer

English

Neoadjuvant Chemotherapy: Role in Breast Cancer

2013English

Neoadjuvant Chemotherapy for Early Breast Cancer – Author's Reply

The Lancet Oncology
Oncology
2018English

Evaluation of Ki-67 Proliferation and Apoptotic Index Before, During and After Neoadjuvant Chemotherapy for Primary Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2006English

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

New England Journal of Medicine
Medicine
2012English

Towards De-Escalation of Axillary Management After Neoadjuvant Chemotherapy in Breast Cancer

English

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews
2019English

Accuracy of Ultrasonography and Mammography in Predicting Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

American Journal of Surgery
MedicineSurgery
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy